| 标题 |
Final Results of Ruxopeg, a Phase 1/2 Adaptive Randomized Trial of Ruxolitinib (Rux) and Pegylated Interferon Alpha (IFNa) 2a in Patients with Myelofibrosis (MF) |
| 网址 | |
| DOI |
10.1182/blood-2022-156389
doi
|
| 其它 |
期刊:Blood 作者:Jean‐Jacques Kiladjian; Jean‐Christophe Ianotto; Juliette Soret; Nabih Maslah; Cendrine Chaffaut; et al 出版日期:2022-11-15 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)